call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Microbiome Therapeutics Market
Inquire Before Buying Request for Sample

Microbiome Therapeutics Market

Home Healthcare And Pharmaceutical Microbiome Therapeutics Market

Microbiome Therapeutics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028, Segmented by Application (Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, Others); By Type (Fecal Microbial Transplant, Drugs); Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)

  • Published Date: October 2022
  • Report ID: BWC22414
  • Available Format: PDF
  • Page: 140

Report Overview

Growing R&D initiatives and investments in developing microbiome technology and drugs to treat growing number of patients with various unmet medical conditions are expected to drive global microbiome therapeutics market at a high growth rate during the forecast period between 2022 and 2028.

Global Microbiome Therapeutics Market - Industry Trends & Forecast Report 2028

Global microbiome therapeutics market size was estimated at USD 91.28 million in 2021. Between 2022 and 2028 (forecast period), the market size is expected to grow at a robust CAGR of 35%, reaching USD 746.3 million by 2028. Major growth factors for global microbiome therapeutics market include increasing investments and support by governments in developed countries in discovery, research, and development programs to understand the human microbiome, technology advancements in developing novel microbiome drugs to treat growing patient populations with significant unmet medical needs in targeted disease areas, and significant collaborations between public and private organizations in the understanding and gaining significant expertise in the human microbiome.

Microbiome – Overview

Microbiome is defined as the group of microorganisms, such as bacteria, fungi, and viruses, living in or on the human body. As a term, microbiome covers all of the genetic material within the community of microorganisms in a specific environment, for example, the human gut. It is estimated that there are nearly 100 trillion microbiomes in a healthy adult human body. Microbiomes has the potential to fight against the diseases. Many scientific research studies found that human gut microbiomes enhance the efficacy and safety of therapeutics. Hence, they are useful for developing human microbiome therapeutics.

Global Microbiome Therapeutics Market - Industry Trends

Increasing R&D to Understand Human Microbiome

The National Institutes of Health (NIH), the national medical research agency in the United States, launched the Human Microbiome Project (HMP), in 2007. The focus of HMP is to gather resources and gain required expertise to characterize the human microbiome and analyze its role in health and disease. The HMP is like a road map for finding the role played by microorganisms in human health, nutrition, immunity, and disease in many parts of the human body. The NIH earmarked a five-year budget of USD 170 million for the project. The HMP supports centers and institutes in the United States conducting research studies on the microbes living in skin, mouth, nose, colon, and vagina. About 80 institutes across the United States are conducting the HMP project.

In Europe, the European Commission funds a collaborative project called MetaHIT (METAgenomics of the Human Intestinal Tract) bringing together 15 institutes from eight countries in the region. The MetaHIT was established in 2012 to mainly focus on the potential of human microbiome therapeutics for inflammatory bowel syndrome (IBS) and obesity. The project’s major results were the establishment of a catalogue of microbial genes from the human gut and the discovery of enterotypes.

Growing prevalence of target diseases 

A main driver behind significant investments in R&D of human microbiome therapeutics is a surge in demand for the development of effective therapeutics for inflammatory bowel disease (IBD), metabolic disorders (such as diabetes and obesity), multiple sclerosis, and rheumatoid arthritis, and the prospects of novel microbiome drugs for significant product developments. For instance, the CDC reported that there were an estimated 1.3% adults (3 million) in the United States diagnosed with IBD (either Crohn's disease or ulcerative colitis) in 2015. There is significant unmet medical needs to address this target disease area alone. Hence, an increasing focus and R&D efforts on developing novel human microbiome therapeutics for treating targeted diseases could drive the global microbiome therapeutics market during the forecast period.

Restraints

High development costs and stringent regulations

The implementation of extremely sophisticated methods has been brought about by the requirement for clinical-grade, thoroughly polished final goods with high safety standards. The initial set of production units for such advanced technological methods involves substantial investments for the companies in the microbiome industry. The primary barrier to the rapid development of microbiome therapeutics for various targeted diseases is the strict regulatory requirements for sanctioning any new development related to the biopharmaceutical sector. The expansion of global microbiome therapeutics market is limited by the lack of comprehensive understanding of microbiomes and the testing and approval of therapeutics based on human microbiomes.

Impact of COVID-19 on Global Microbiome Therapeutics Market

Covid-19 pandemic highlighted the significance of developing novel drugs for comorbidities, including IBS and metabolic disorders (diabetes and obesity), for the world population. It, in turn, is expected to positively impact the discovery and development of microbiome therapeutics. However, the onset of Covid-19 pandemic and resultant lockdowns affected various clinical trials, including on the microbiome therapeutics, across the US and Europe. Post Covid-19 and relaxation of business and travel curbs could help accelerate the development of novel microbiome drugs.

 

Segmental Coverage

Global Microbiome Therapeutics Market – By Application

Global microbiome therapeutics market by application is segmented into inflammatory bowel disease (IBD), diabetes, multiple sclerosis, rheumatoid arthritis, and others. Among these application areas, the IBD segment held the largest market share and is expected to continue holds the major share in global microbiome therapeutics market by application during the period in analysis.

Global Microbiome Therapeutics Market – By Type

Based on type, global microbiome therapeutics market is divided into fecal microbial transplant and drugs. The fecal microbial transplant treatment type holds a higher market share in global microbiome therapeutics market. However, the drugs segment is expected to grow at a higher CAGR during the forecast period, as novel human microbiome drug candidates in various development phases are expected to gain market approvals.

Microbiome Therapeutics Market Share

Regional Insights

North America holds the highest market share and is expected to continue its dominance in the global microbiome therapeutics market. The presence of a sizable number of centers and institutes involved in the R&D of advanced medicines is one of the key factors for the growth of North America microbiome therapeutics market. The United States federal agencies' investments in the country's microbiome research are expected to boost the market's expansion in North America. Europe is the second largest region in the global microbiome therapeutics market. The European Commission’s collaborative project, METAgenomics of the Human Intestinal Tract (MetaHIT) provides significant resources, expertise, and support for the development of microbiome therapeutics for IBS and metabolic disorders.

Competitive Landscape

The global microbiome therapeutics market consists of prominent players, such as 4D Pharma Plc, AOBiome LLC, AvidBiotics, Enterome SA, Evelo Biosciences, Ferring B.V., Immuron Ltd., LNC Therapeutics Inc., Microbiome Therapeutics Inc., Osel Inc., OxThera AB, Rebiotix, Ritter Pharmaceuticals, Second Genome Therapeutics, SERES Therapeutics Inc., Synlogic Inc., Vedanta Biosciences Inc., and ViThera Pharmaceuticals Inc. These companies indulge in various strategies, including mergers and acquisitions, partnerships, joint ventures, licensing agreements, and collaborations, to discover and develop novel microbiome therapeutics for targeted diseases.

 

Recent Developments

  • In March 2022 - 4D Pharma Plc, a leading developer of Live Biotherapeutic Products (LBPs), a novel class of drug derived from the microbiome, announced the positive interim results from Part I/II study of the combination of its MRx0518 with Merck & Co's Keytruda (pembrolizumab), an anti-PD-1 therapy, in the renal cell carcinoma (RCC) patient group.

  • In February 2022 - AOBiome Therapeutics, a clinical stage biotech company involved in developing topical biologic therapies for systemic inflammatory conditions, announced positive pivotal Phase 2b results from its trial evaluating B244, the company’s topical and intranasal formulation, in pruritus (itch) and appearance of atopic dermatitis (eczema). 

 

Scope of the Report

Attributes

Details

Year considered

Historical Data – 2018–2021

Base Year – 2021

Estimated Year – 2022

Forecast – 2022–2028

Facts Covered

 Revenues in USD million 

Market coverage

North America (US, Canada), Europe (Germany, United Kingdom, Italy, France, Spain, The Netherlands, Belgium, Nordic Countries, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Philippines, Vietnam, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Peru, Colombia, Rest of Latin America), Middle East and Africa (Saudi Arabia, UAE, Qatar, Kuwait, Iran, South Africa, Nigeria, Kenya, Egypt, Morocco, Algeria, Rest of Middle East and Africa)

Product/Service Segmentation

Application, Type, Region

Key Players

4D Pharma Plc, AOBiome LLC, AvidBiotics, Enterome SA, Evelo Biosciences, Ferring B.V., Immuron Ltd., LNC Therapeutics Inc., Microbiome Therapeutics Inc., Osel Inc., OxThera AB, Rebiotix, Ritter Pharmaceuticals, Second Genome Therapeutics, SERES Therapeutics Inc., Synlogic Inc., Vedanta Biosciences Inc., ViThera Pharmaceuticals Inc.

 

By Application

  • Inflammatory Bowel Disease (IBD)
  • Diabetes
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Others

By Type

  • Fecal Microbial Transplant
  • Drugs

    By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
  1. Research Framework
    1. Research Objective
    2. Type Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Microbiome Therapeutics Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Advancements in microbiome technology to develop novel products
        2. Growing prevalence of target diseases
        3. Increasing R&D to understand human microbiome
      2. Restraints
        1. High development and production costs
        2. Negative clinical data adversely affect public perception of microbiome
      3. Opportunity
        1. Strengthening collaboration between public and private organizations
      4. Challenges
        1. Lack of expertise and inadequate research
        2. Stringent government regulations
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Microbiome Therapeutics Market Overview
    1. Market Size & Forecast, by Value, 2018–2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Application
        1. Inflammatory Bowel Disease (IBD)
        2. Diabetes
        3. Multiple Sclerosis
        4. Rheumatoid Arthritis
        5. Others
      2. By Type
        1. Fecal Microbial Transplant
        2. Drugs
      3. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America
        5. Middle East and Africa (MEA)
  5. North America Microbiome Therapeutics Market
      1. Market Size & Forecast, by Value, 2018–2028
      2. By Value (USD Million)
    2. Market Share & Forecast
      1. By Application
      2. By Type
      3. By Country
        1. United States
          1. By Application
          2. By Type
        2. Canada
          1. By Application
          2. By Type
  6. Europe Microbiome Therapeutics Market
    1. Market Size & Forecast, by Value, 2018–2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Application
      3. By Country
        1. Germany
          1. By Application
          2. By Type
        2. United Kingdom
          1. By Application
          2. By Type
        3. Italy
          1. By Application
          2. By Type
        4. France
          1. By Application
          2. By Type
        5. Spain
          1. By Application
          2. By Type
        6. The Netherlands
          1. By Application
          2. By Type
        7. Belgium
          1. By Application
          2. By Type
        8. NORDIC Countries
          1. B By Application
          2. By Type
        9. Rest of Europe
          1. By Application
          2. By Type
  7. Asia Pacific Microbiome Therapeutics Market
    1. Market Size & Forecast, by Value, 2018–2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Application
      3. By Country
        1. China
          1. By Application
          2. By Type
        2. India
          1. By Application
          2. By Type
        3. Japan
          1. By Application
          2. By Type
        4. South Korea
          1. By Application
          2. By Type
        5. Australia & New Zealand
          1. By Application
          2. By Type
        6. Indonesia
          1. By Application
          2. By Type
        7. Malaysia
          1. By Application
          2. By Type
        8. Singapore
          1. By Application
          2. By Type
        9. Philippines
          1. By Application
          2. By Type
        10. Vietnam
          1. By Application
          2. By Type
        11. Rest of Asia Pacific
          1. By Application
          2. By Type
  8. Latin America Microbiome Therapeutics Market
    1. Market Size & Forecast, by Value, 2018–2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Application
      3. By Country
        1. Brazil
          1. By Application
          2. By Type
        2. Mexico
          1. By Application
          2. By Type
        3. Argentina
          1. By Application
          2. By Type
        4. Peru
          1. By Application
          2. By Type
        5. Colombia
          1. By Application
          2. By Type
        6. Rest of Latin America
          1. By Application
          2. By Type
  9.  Middle East & Africa Microbiome Therapeutics Market
    1. Market Size & Forecast, by Value, 2018–2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Application
      3. By Country
        1. Saudi Arabia
          1. By Application
          2. By Type
        2. UAE
          1. By Application
          2. By Type
        3. Qatar
          1. By Application
          2. By Type
        4. Kuwait
          1. By Application
          2. By Type
        5. Iran
          1. By Application
          2. By Type
        6. South Africa
          1. By Application
          2. By Type
        7. Nigeria
          1. By Application
          2. By Type
        8. Kenya
          1. By Application
          2. By Type
        9. Egypt
          1. By Application
          2. By Type
        10. Morocco
          1. By Application
          2. By Type
        11. Algeria
          1. By Application
          2. By Type
        12. Rest of Middle East & Africa
          1. By Application
          2. By Type
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Microbiome Therapeutics Company Market Share Analysis, 2021
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
  11. Impact of Covid-19 on Global Microbiome Therapeutics Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT)
    1. 4D Pharma Plc.
    2. AOBiome LLC
    3. AvidBiotics
    4. Enterome SA
    5. Evelo Biosciences
    6. Ferring B.V.
    7. Immuron Ltd.
    8. LNC Therapeutics Inc.
    9. Microbiome Therapeutics Inc.
    10. Osel Inc.
    11. OxThera AB
    12. Rebiotix
    13. Ritter Pharmaceuticals
    14. Second Genome Therapeutics
    15. SERES Therapeutics Inc.
    16. Synlogic Inc.
    17. Vedanta Biosciences Inc.
    18. ViThera Pharmaceuticals Inc.
    19. Others
  13. Key Strategic Recommendations
  14. Research Methodology
    1. Qualitative Research
      1. Primary & Secondary Research
    2. Quantitative Research
    3. Market Breakdown & Data Triangulation
      1. Secondary Research
      2. Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5. Assumptions & Limitations

 

*Financial in case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

 

 

LOF

 

Figure 1        Global Microbiome Therapeutics Segmentation

Figure 2        Global Microbiome Therapeutics Market Value Chain Analysis

Figure 3        Company Share Analysis, 2021

Figure 4        Global Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 5        Global Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 6        Global Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 7        Global Microbiome Therapeutics Market Share, By Region, By Value, 2018–2028

Figure 8        North America Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 9        North America Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 10       North America Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 11       North America Microbiome Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 12       United States Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 13       United States Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 14       United States Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 15       Canada Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 16       Canada Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 17       Canada Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 18       Europe Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 19       Europe Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 20       Europe Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 21       Europe Microbiome Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 22       Germany Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 23       Germany Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 24       Germany Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 25       United Kingdom Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 26       United Kingdom Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 27       United Kingdom Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 28       Italy Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 29       Italy Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 30       Italy Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 31       France Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 32       France Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 33       France Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 34       Spain Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 35       Spain Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 36       Spain Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 37       The Netherlands Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 38       The Netherlands Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 39       The Netherlands Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 40       Belgium Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 41       Belgium Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 42       Belgium Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 43       NORDIC Countries Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 44       NORDIC Countries Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 45       NORDIC Countries Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 46       Rest of Europe Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 47       Rest of Europe Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 48       Rest of Europe Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 49       Asia-Pacific Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 50       Asia-Pacific Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 51       Asia-Pacific Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 52       Asia-Pacific Microbiome Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 53       China Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 54       China Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 55       China Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 56       India Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 57       India Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 58       India Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 59       Japan Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 60       Japan Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 61       Japan Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 62       South Korea Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 63       South Korea Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 64       South Korea Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 65       Indonesia Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 66       Indonesia Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 67       Indonesia Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 68       Malaysia Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 69       Malaysia Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 70       Malaysia Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 71       Singapore Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 72       Singapore Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 73       Singapore Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 74       Philippines Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 75       Philippines Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 76       Philippines Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 77       Vietnam Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 78       Vietnam Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 79       Vietnam Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 80       Rest of Asia Pacific Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 81       Rest of Asia Pacific Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 82       Rest of Asia Pacific Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 83       Latin America Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 84       Latin America Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 85       Latin America Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 86       Latin America Microbiome Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 87       Brazil Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 88       Brazil Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 89       Brazil Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 90       Mexico Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 91       Mexico Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 92       Mexico Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 93       Peru Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 94       Peru Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 95       Peru Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 96       Colombia Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 97       Colombia Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 98       Colombia Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 99       Rest of Latin America Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 100     Rest of Latin America Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 101     Rest of Latin America Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 102     Middle East & Africa Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 103     Middle East & Africa Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 104     Middle East & Africa Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 105     Middle East & Africa Microbiome Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 106     Saudi Arabia Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 107     Saudi Arabia Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 108     Saudi Arabia Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 109     UAE Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 110     UAE Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 111     UAE Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 112     Qatar Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 113     Qatar Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 114     Qatar Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 115     Iran Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 116     Iran Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 117     Iran Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 118     Nigeria Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 119     Nigeria Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 120     Nigeria Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 121     Kenya Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 122     Kenya Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 123     Kenya Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 124     Egypt Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 125     Egypt Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 126     Egypt Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 127     Morocco Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 128     Morocco Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 129     Morocco Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 130     Algeria Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 131     Algeria Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 132     Algeria Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

Figure 133     Rest of Middle East & Africa Microbiome Therapeutics Market Size, By Value (USD Million), 2018–2028

Figure 134     Rest of Middle East & Africa Microbiome Therapeutics Market Share, By Application, By Value, 2018–2028

Figure 135     Rest of Middle East & Africa Microbiome Therapeutics Market Share, By Type, By Value, 2018–2028

 

LOT

 

Table 1         Global Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                 

Table 2         Global Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                               

Table 3         Global Microbiome Therapeutics Market Size, By Region, By Value, 2018–2028                            

Table 4         North America Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                     

Table 5         North America Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                              

Table 6         United States Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                     

Table 7         United States Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                               

Table 8         Canada Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                               

Table 9         Canada Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                              

Table 10        Europe Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                

Table 11        Europe Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                              

Table 12        Europe Microbiome Therapeutics Market Size, By Country, By Value, 2018–2028                                    

Table 13        Germany Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                             

Table 14        Germany Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                     

Table 15        United Kingdom Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                     

Table 16        United Kingdom Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                   

Table 17        Italy Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                   

Table 18        Italy Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                 

Table 6         France Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                

Table 7         France Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                               

Table 8         Spain Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                  

Table 9         Spain Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                

Table 10        The Netherlands Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                               

Table 11        The Netherlands Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                   

Table 12        Belgium Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                              

Table 13        Belgium Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                             

Table 14        NORDIC Countries Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                               

Table 15        NORDIC Countries Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                     

Table 16        Rest of Europe Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                     

Table 17        Rest of Europe Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                              

Table 18        Asia-Pacific Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                     

Table 19        Asia-Pacific Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                  

Table 20        Asia-Pacific Microbiome Therapeutics Market Size, By Country, By Value, 2018–2028                              

Table 21        China Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                  

Table 22        China Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                

Table 23        India Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                  

Table 24        India Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                 

Table 25        Japan Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                  

Table 39        Japan Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                

Table 40        South Korea Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                     

Table 41        South Korea Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                 

Table 42        Indonesia Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                     

Table 43        Indonesia Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                    

Table 44        Malaysia Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                              

Table 45        Malaysia Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                      

Table 46        Singapore Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                     

Table 47        Singapore Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                    

Table 48        Philippines Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                     

Table 49        Philippines Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                   

Table 50        Vietnam Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                              

Table 51        Vietnam Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                            

Table 52        Rest of Asia Pacific Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                               

Table 53        Rest of Asia Pacific Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                     

Table 54        Latin America Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                     

Table 55        Latin America Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                               

Table 56        Latin America Microbiome Therapeutics Market Size, By Country, By Value, 2018–2028                                  

Table 57        Brazil Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                  

Table 58        Brazil Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                

Table 59        Mexico Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                

Table 60        Mexico Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                              

Table 61        Peru Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                   

Table 62        Peru Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                  

Table 63        Colombia Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                             

Table 64        Colombia Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                     

Table 65        Rest of Latin America Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                               

Table 66        Rest of Latin America Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                     

Table 67        Middle East & Africa Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                               

Table 68        Middle East & Africa Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                     

Table 69        Middle East & Africa Microbiome Therapeutics Market Size, By Country, By Value, 2018–2028                               

Table 70        Saudi Arabia Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                     

Table 71        Saudi Arabia Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                 

Table 72        UAE Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                    

Table 73        UAE Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                  

Table 74        Qatar Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                  

Table 75        Qatar Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                

Table 76        Iran Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                    

Table 77        Iran Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                  

Table 78        Nigeria Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                

Table 79        Nigeria Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                              

Table 80        Kenya Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                 

Table 81        Kenya Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                               

Table 82        Egypt Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                  

Table 83        Egypt Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                                

Table 84        Morocco Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                              

Table 85        Morocco Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                             

Table 86        Algeria Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                

Table 87        Algeria Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                              

Table 88        Rest of Middle East & Africa Microbiome Therapeutics Market Size, By Application, By Value, 2018–2028                                 

Table 89        Rest of Middle East & Africa Microbiome Therapeutics Market Size, By Type, By Value, 2018–2028                               

Table 90        4D Pharma Plc. Company Overview                            

Table 91        4D Pharma Plc. Financial Overview                             

Table 92        AOBiome LLC Company Overview                               

Table 93        AOBiome LLC Financial Overview                                

Table 94        AvidBiotics Company Overview                                  

Table 95        AvidBiotics Financial Overview                                   

Table 96        Enterome SA Company Overview                               

Table 97        Enterome SA Financial Overview                                

Table 98        Evelo Biosciences Company Overview                                   

Table 99        Evelo Biosciences Financial Overview                                    

Table 100      Ferring B.V. Company Overview                                 

Table 101      Ferring B.V. Financial Overview                                  

Table 102      Immuron Ltd. Company Overview                              

Table 103      Immuron Ltd. Financial Overview                               

Table 104      LNC Therapeutics Inc. Company Overview                             

Table 105      LNC Therapeutics Inc. Financial Overview                              

Table 106      Microbiome Therapeutics Inc. Company Overview                             

Table 107      Microbiome Therapeutics Inc. Financial Overview                              

Table 108      Osel Inc. Company Overview                                     

Table 109      Osel Inc. Financial Overview                            

Table 110      OxThera AB Company Overview                                 

Table 111      OxThera AB Financial Overview                                  

Table 112      SERES Therapeutics Inc. Company Overview                                   

Table 113      SERES Therapeutics Inc. Financial Overview                                    

Table 114      Synlogic Inc. Company Overview                                

Table 115      Synlogic Inc. Financial Overview                                

Table 116      Vedanta Biosciences Inc. Company Overview                                   

Table 117      Vedanta Biosciences Inc. Financial Overview                                    

Table 118      ViThera Pharmaceuticals Inc. Company Overview                             

Table 119      ViThera Pharmaceuticals Inc. Financial Overview

 

Market Segmentation

By Application

  • Inflammatory Bowel Disease (IBD)
  • Diabetes
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Others

By Type

  • Fecal Microbial Transplant
  • Drugs

    By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Major growth factors for Global Microbiome Therapeutics Market include microbiome’s estimated potential in treating unmet medical needs and advancements in microbiome technology to develop novel products.
Ans: North America held the highest market share in Global Microbiome Therapeutics Market.
Ans: Global Microbiome Therapeutics Market size reached a value of USD 91.28 million in 2021.
Ans: Major growth factors for Global Microbiome Therapeutics Market include microbiome’s estimated potential in treating unmet medical needs and advancements in microbiome technology to develop novel products.